NASDAQ: THRM

Gentherm Inc

CIK 0000903129 · SIC 3714 · Motor Vehicle Parts & Accessories

Mid Revenue $1.5B Assets $1.6B as of Nov 15, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (JEF 10-Q) is open in full — no account needed.

10-Q Filed Oct 22, 2026 · Period ending Sep 30, 2026

Summary not yet generated.

8-K Filed Oct 22, 2026 · Period ending Oct 22, 2026

Summary not yet generated.

Partner

Trade THRM commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Oct 1, 2026 · Period ending Sep 29, 2026

Summary not yet generated.

8-K Filed Sep 11, 2026 · Period ending Sep 10, 2026

Summary not yet generated.

424B3 Filed Aug 12, 2026 Red flag

Gentherm to acquire Modine's Performance Technologies Business for ~20.8M shares in reverse Morris Trust, diluting existing shareholders by 40%

9 material changes detected. Sign up free to read the summary.

10-Q Filed Jul 23, 2026 · Period ending Jun 30, 2026 Red flag

revenue $416.2M, net income $4.4M. Gentherm revenue +11% but operating income -55% on Modine M&A costs; warranty accrual triples

5 material changes detected. Sign up free to read the summary.

8-K Filed Jul 23, 2026 · Period ending Jul 23, 2026

Gentherm raises FY2026 guidance, authorizes up to $400M buyback replacing up to $150M program

5 material changes detected. Sign up free to read the summary.

8-K Filed Jul 2, 2026 · Period ending Jun 29, 2026

Gentherm enters $550M 5-year revolving credit facility with leverage-based pricing

4 material changes detected. Sign up free to read the summary.

8-K Filed May 19, 2026 · Period ending May 14, 2026

Gentherm shareholders approve 1.7M share increase to equity incentive plan

5 material changes detected. Sign up free to read the summary.

8-K Filed Apr 23, 2026 · Period ending Apr 23, 2026

Summary not yet generated.

10-Q Filed Apr 23, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

8-K Filed Mar 25, 2026 · Period ending Mar 24, 2026

Summary not yet generated.

10-K Filed Feb 19, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Oct 23, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q Filed Jul 24, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-K Filed Feb 19, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Oct 22, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Consolidated Condensed Statements of (Loss) Income (Unaudited)

(In thousands, except per share data)

Description Three months ended September 30, 2026 Three months ended September 30, 2025 Nine months ended September 30, 2026 Nine months ended September 30, 2025
Product revenues 405,102 386,870 1,214,974 1,115,814
Cost of sales 310,798 291,722 927,016 844,439
Gross margin 94,304 95,148 287,958 271,375
Operating expenses:
Net research and development expenses 23,465 24,429 71,480 71,203
Selling, general and administrative expenses 51,638 42,875 162,648 122,440
Restructuring expenses, net 4,838 3,986 17,493 10,608
Loss on sale of land and building, net — — — 2,196
Total operating expenses 79,941 71,290 251,621 206,447
Operating income 14,363 23,858 36,337 64,928
Interest expense, net (3,832) (3,313) (9,755) (10,911)
Foreign currency gain (loss) 193 339 (1,104) (27,391)
Other income (loss) 116 — 300 (1,124)
Earnings before income tax 10,840 20,884 25,778 25,502
Income tax expense 13,430 5,935 19,730 10,204
Net (loss) income (2,590) 14,949 6,048 15,298
Basic (loss) earnings per share (0.08) 0.49 0.20 0.50
Diluted (loss) earnings per share (0.08) 0.49 0.19 0.50
Weighted average number of shares basic 30,672 30,480 30,613 30,619
Weighted average number of shares diluted 30,672 30,748 31,078 30,802

Consolidated Condensed Balance Sheets (Unaudited)

(In thousands, except share data)

Description September 30, 2026 December 31, 2025
ASSETS
Current Assets:
Cash and cash equivalents 252,098 160,833
Accounts receivable, net 326,217 281,083
Inventory:
Raw materials 127,403 128,314
Work in process 44,437 35,429
Finished goods 91,647 88,959
Inventory, net 263,487 252,702
Other current assets 85,678 82,332
Total current assets 927,480 776,950
Property and equipment, net 263,561 270,614
Goodwill 122,258 108,918
Other intangible assets, net 63,858 52,796
Operating lease right-of-use assets 48,674 56,524
Deferred income tax assets 93,853 93,552
Other non-current assets 42,615 37,075
Total assets 1,562,299 1,396,429
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable 298,183 260,487
Current lease liabilities 7,846 9,646
Current maturities of long-term debt 912 73
Other current liabilities 144,999 134,104
Total current liabilities 451,940 404,310
Long-term debt, less current maturities 319,531 189,000
Non-current lease liabilities 42,469 48,105
Pension benefit obligation 3,281 3,748
Other non-current liabilities 23,760 30,943
Total liabilities 840,981 676,106
Shareholders’ Equity:
Common Stock:
No par value; 110,000,000 shares authorized 30,710,902 and 30,526,231 issued and outstanding at September 30, 2026 and December 31, 2025, respectively 13,442 5,611
Paid-in capital 1,590 1,590
Accumulated other comprehensive loss (13,848) (964)
Accumulated earnings 720,134 714,086
Total shareholders’ equity 721,318 720,323
Total liabilities and shareholders’ equity 1,562,299 1,396,429

Consolidated Condensed Statements of Cash Flows (Unaudited)

(In thousands)

Description Nine months ended September 30, 2026 Nine months ended September 30, 2025
Operating Activities:
Net income 6,048 15,298
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 44,201 39,478
Deferred income taxes (9,548) (12,836)
Stock based compensation 10,371 10,573
Loss on disposition of property and equipment 121 2,671
Provisions for inventory 4,086 5,234
Other non-cash items, including unrealized foreign currency (gain) loss (1,018) 30,957
Changes in assets and liabilities:
Accounts receivable, net (43,474) (20,543)
Inventory (22,133) (20,136)
Other assets (1,403) (22,325)
Accounts payable 43,305 33,514
Other liabilities 5,451 25,935
Net cash provided by operating activities 36,007 87,820
Investing Activities:
Purchases of property and equipment (22,558) (33,378)
Proceeds from the sale of property and equipment 83 3,770
Acquisition of business, net of cash acquired (34,152) —
Cost of technology investments (121) (915)
Proceeds from deferred purchase price of factored receivables — 744
Net cash used in investing activities (56,748) (29,779)
Financing Activities:
Borrowings on debt 204,000 72,000
Repayments of debt (85,887) (103,112)
Cash paid for financing new loans (2,761) —
Taxes withheld and paid on employees' stock based compensation (2,540) (1,306)
Cash paid for the repurchase of Common Stock — (10,015)
Net cash provided by (used in) financing activities 112,812 (42,433)
Foreign currency effect (806) 4,508
Net increase in cash and cash equivalents 91,265 20,116
Cash and cash equivalents at beginning of period 160,833 134,134
Cash and cash equivalents at end of period 252,098 154,250
Supplemental disclosure of cash flow information:
Cash paid for interest 9,059 9,835
Non-Cash Investing Activities:
Period-end balance of accounts payable for property and equipment 3,794 2,959

Amounts as printed on the EDGAR/iXBRL face — (In thousands, except per share data); (In thousands, except share data); (In thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗